FM
ZBH icon

Foster & Motley’s Zimmer Biomet ZBH Stock Holding History

Foster & Motley’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
2,691
-320
-11% -$28.1K 0.01% 392
2026
Q1 		$272K Sell
3,011
-204
-6% -$18.7K 0.01% 364
2025
Q4 		$289K Sell
3,215
-252
-7% -$23.9K 0.02% 347
2025
Q3 		$342K Buy
3,467
+1,111
+47% +$110K 0.02% 331
2025
Q2 		$215K Buy
+2,356
New +$228K 0.01% 380
2024
Q2 		– Sell
-1,931
Closed -$255K – 399
2024
Q1 		$255K Sell
1,931
-478
-20% -$59.7K 0.02% 355
2023
Q4 		$293K Sell
2,409
-473
-16% -$52.8K 0.02% 328
2023
Q3 		$323K Buy
+2,882
New +$366K 0.03% 312

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Foster & Motley's ZBH Position: Q2 2026 in Review

Foster & Motley reduced its Zimmer Biomet (ZBH) stake by 11% in Q2 2026, selling an estimated $28.1K and leaving 2,691 shares worth $232K. The position accounts for 0.01% of the portfolio, ranked #392.

Foster & Motley first reported a position in ZBH in Q3 2023 and has held it in 8 quarters since. The position peaked at $342K in Q3 2025. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Foster & Motley held 2,691 shares of Zimmer Biomet worth $232K as of Q2 2026.
  • Foster & Motley sold 320 Zimmer Biomet shares in Q2 2026, an estimated $28.1K.
  • Zimmer Biomet made up 0.01% of Foster & Motley's portfolio in Q2 2026, its #392 holding.
  • Foster & Motley first reported a position in Zimmer Biomet in Q3 2023 and has held it in 8 quarters since.
  • Foster & Motley's Zimmer Biomet position peaked at $342K in Q3 2025.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Foster & Motley's 13F filing for Q2 2026, filed 7 Aug 2026.